Long-term effects of SARS-CoV-2 vaccination in the nursing home setting.

Giulia RivasiMatteo BulgaresiChiara BandinelliDaniela BalziFrancesca TarantiniSilvia TognelliChiara LoriniPrimo BuscemiLorenzo BaggianiGiancarlo LandiniAndrea UngarGuglielmo BonaccorsiEnrico MosselloEnrico Benvenuti

Published in: Journal of the American Geriatrics Society (2022)

Among vaccinated NH residents, rates of breakthrough SARS-CoV-2 infection, hospitalization and lethality remained low up to 9 months following primary vaccination course. A mild resurgence of SARS-CoV-2 infection, after 6 months from vaccination, suggests a decline of vaccine effectiveness in preventing transmission.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
systematic review
room temperature